<DOC>
	<DOC>NCT02667470</DOC>
	<brief_summary>The objective of this study is to evaluate change of Overactive Bladder (OAB) Symptom Score (OABSS) scores between before and after Solifenacin treatment to OAB patients and to evaluate correlation between change of OABSS scores and other measures for OAB symptoms.</brief_summary>
	<brief_title>Reproducibility Study of OABSS and Its Response to Treatment</brief_title>
	<detailed_description />
	<mesh_term>Urinary Bladder, Overactive</mesh_term>
	<mesh_term>Solifenacin Succinate</mesh_term>
	<criteria>At screening visit (Week 2): Symptoms of OAB ≥ 3 months Number of urgency episodes in last 3 days ≥ 3 Based on the 3day micturition diary prior to Visit 1 (Week 0): Number of micturition per day ≥ 8 Number of urgency episodes in 3 days ≥ 3 At screening visit (Week 2): Stress is the predominant factor as determined by the investigator Indwelling catheters or practicing intermittent selfcatheterization Symptomatic urinary tract infection, chronic inflammation Treatment for OAB was started, quitted or changed in 4 weeks Diabetic neuropathy At Visit 1 (Week 0): Patient who did not complete the 3day micturition diary according to the instruction</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2016</verification_date>
	<keyword>Solifenacin</keyword>
	<keyword>Overactive bladder</keyword>
</DOC>